Furthermore, the global oncology/cancer drugs market growth is propelled by surge in geriatric population, increase in collaboration between pharmaceutical companies for development of novel cancer drugs, and rise in awareness associated with early detection of cancer among populace.
Tag Archives: Cancer Drugs
Oncology/Cancer Drugs Market Expected to reach $274.40 Billion by 2030 | By Allied Market Research
North America accounted for the largest share of revenue in 2020, and is anticipated to maintain its dominance from 2021 to 2030, owing to presence of large patient population, strong presence of key players, ease of drug availability.
Oncology-Cancer Drugs Market | Industry, Revenue & Trends Analysis From 2021 To 2030
The global oncology drugs market size was valued at $135,494.17 million in 2020, and is projected to reach $274,400.63 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.
Top 10 Cancer Drugs Market Size to Reach Revenues of over $129.94 Bn by 2026
Allied Market Research published a report, titled, “Top 10 Cancer Drugs Market by Region (Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2018–2026.” According to the report, the global top 10 cancer drugs industry generated $63.61 billion in 2018, and is estimated to reach $129.94 billion by 2026, witnessing a CAGR of 9.8% from …
Continue reading “Top 10 Cancer Drugs Market Size to Reach Revenues of over $129.94 Bn by 2026”